Ramneet Kaur Basra, PA-C

Ramneet Basra practices at Integrated Dermatology of Lincoln in Boca Raton, Florida.

Ramneet Basra's NPI, 1457874893, was assigned on July 18, 2017. Ramneet Basra holds California license 54543.

Ramneet Basra's primary practice is Integrated Dermatology of Lincoln, at 4700 Exchange Ct, Boca Raton, FL 33431 in Palm Beach County. The practice phone is (530) 527-0414.

Ramneet Basra's primary practice is Integrated Dermatology of Lincoln in Boca Raton, Florida. Ramneet Basra is also affiliated with Oroville Hospital. The medical group on file is Integrated Dermatology. Dmand AI also links Ramneet Basra to 3 more medical groups and 2 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Ramneet Basra practices, 3 sites in all. Vendor and product names are available with a free account.

Medical is Ramneet Basra's primary specialty in the NPI Registry, under taxonomy code 363AM0700X. Ramneet Basra is licensed in California.

Dmand AI lists acne, acute skin infection, anxiety, benign or precancerous skin growths, contact dermatitis, facial skin infection, head wound and hives among the conditions Ramneet Basra treats.

CMS data shows 2,411 Medicare services from Ramneet Basra across 14 procedure codes in 2024, for 477 Medicare patients. Medicare paid $73,332 for them. Every service was in an office.

CMS counts 477 Medicare patients who saw Ramneet Basra in 2024. The largest group is 65 to 74, with 222 patients. 75% of them have high cholesterol, and 68% have high blood pressure. 21% are also on Medicaid. Their average risk score is 0.97, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Ramneet Basra's median patient age at 66, with 52% women.

In 2024, Ramneet Basra wrote 595 Medicare Part D claims for 246 patients. 95% of them were for generic drugs. CMS names the drug for 462 of them, across 11 drugs with 11 or more claims each, at $11,851 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Ramneet Basra for performance year 2024, reported as part of a group. Ramneet Basra accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 34 general payments to Ramneet Basra from 12 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 93% of the total. Novartis Pharmaceuticals Corporation paid the most, $169.